During the early 1970s, the FDA started two new forums to increase drug communication with the public. The Bureau of Drugs launched the FDA Drug Bulletin in 1971. The Bulletin alerted physicians and pharmacists to changes in drug use and labeling requirements. The National Drug Experience Reporting System also began in 1971. The NAS had been studying the problem of not only how to catalogue and store information about adverse drug reactions, drug abuse, and drug interactions, but also how that information could be made available to health professionals. The study concluded that since FDA had already collected the data, they should take the lead on creating and maintaining the system.